Biodesix, Inc. Files 8-K on Financials
Ticker: BDSX · Form: 8-K · Filed: May 13, 2025 · CIK: 1439725
| Field | Detail |
|---|---|
| Company | Biodesix Inc (BDSX) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Biodesix filed an 8-K on 5/13/25 for financial updates.
AI Summary
On May 13, 2025, Biodesix, Inc. filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details beyond its classification as a current report.
Why It Matters
This 8-K filing indicates that Biodesix, Inc. is providing updates on its financial condition and operations, which is important for investors to monitor the company's performance.
Risk Assessment
Risk Level: low — This filing is a standard 8-K report for financial information and does not contain any immediately alarming or significant new risks.
Key Players & Entities
- Biodesix, Inc. (company) — Registrant
- May 13, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Louisville, Colorado (location) — Principal Executive Office
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but specific figures are not detailed in the provided text.
When was this 8-K report filed?
The report was filed on May 13, 2025.
What is the principal business address of Biodesix, Inc.?
The principal executive office is located at 919 West Dillon Rd, Louisville, Colorado 80027.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for Biodesix, Inc.?
The Standard Industrial Classification code for Biodesix, Inc. is 8071, which corresponds to Medical Laboratories.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding BIODESIX INC (BDSX).